FIELD: medicine.
SUBSTANCE: invention relates to group of the new compounds presented by structural formulas A-K ,
and their pharmaceutically acceptable isomers, salts, salvates and to polymorphous forms.
EFFECT: inhibitory action with respect to thrombin receptors.
20 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
N1-(4-(5-(CYCLOPROPYLMETHYL)-1-METHYL-1H-PYRAZOLE-4-YL)PYRIDINE-2-YL)CYCLOHEXANE-1,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF CK1 AND/OR IRAK1 FOR THE TREATMENT OF CANCER | 2018 |
|
RU2761457C2 |
FURO[3,2-B]PYRAN DERIVATIVES, APPLICABLE IN SYNTHESIS OF ANALOGUES | 2011 |
|
RU2579511C2 |
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
CONDENSED BICYCLIC COMPOUNDS FOR TREATING DISEASE | 2015 |
|
RU2741387C2 |
ISOXAZOLINES AND ISOXAZOLES, METHOD OF INHIBITION OF PLATELET AGGREGATION, PHARMACEUTICAL COMPOSITION INHIBITING PLATELET AGGREGATION | 1994 |
|
RU2149871C1 |
TREATING CONDITIONS ASSOCIATED WITH HYPERINSULINEMIA | 2015 |
|
RU2722179C2 |
COURSE OF TREATMENT WITH APPLICATION OF RECEPTOR S1P AGONIST | 2005 |
|
RU2478384C2 |
AMINOGUAMIDINES, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION BASED THEREON | 1992 |
|
RU2095347C1 |
NEW FIVE-MEMBER HETEROCYCLES, THEIR PREPARING, THEIR APPLYING AND PHARMACEUTICAL PREPARATIONS COMPRISING THEREOF | 1998 |
|
RU2240326C2 |
NEW BICYCLIC PYRAZOLE DERIVATIVES | 2018 |
|
RU2781426C2 |
Authors
Dates
2009-09-20—Published
2004-09-23—Filed